GLP-1 Receptor Agonists: Metabolic Health Risks in Youth
Comments Off on GLP-1 Receptor Agonists: Metabolic Health Risks in Youth
May 10, 2026
Pancreatic fat accumulation is a key factor in metabolic dysfunction among youth. It independently predicts insulin resistance and cardiometabolic risk in obese children. Understanding this helps guide early intervention with GLP-1 receptor agonists.
GLP-1 Receptor Agonists: Clinical Evidence for Type 2 Diabetes
Comments Off on GLP-1 Receptor Agonists: Clinical Evidence for Type 2 Diabetes
April 24, 2026
Oral semaglutide type 2 diabetes clinical evidence demonstrates significant HbA1c reduction in pediatric patients. This oral GLP-1 receptor agonist offers an alternative to injections, improving adherence. It expands treatment options for children and…